Increased expression of toll-like receptor 2 in rat diabetic nephropathy

Fanglin Li1, Niansheng Yang, Lili Zhang

  • 1Department of Nephrology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Abstract

Insights

Toll-like receptor 2 (TLR2) is upregulated in diabetic nephropathy (DN) kidneys, correlating with inflammation and injury. High glucose also increases TLR2 expression in kidney cells, suggesting a key role in DN pathogenesis.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Diabetic nephropathy (DN) pathogenesis involves inflammation.
  • Toll-like receptor 2 (TLR2) is a potential mediator in kidney disease.

Purpose of the Study:

  • To investigate the role of TLR2 in a rat model of diabetic nephropathy.
  • To assess the relationship between TLR2 expression and renal injury markers.

Main Methods:

  • Diabetic nephropathy induced by streptozotocin in rats.
  • Assessed functional, pathological, and inflammatory markers, including TLR2, MCP-1, MyD88, NF-kappaB activation, and macrophage infiltration.
  • In vitro study on high glucose effects on TLR2 expression in renal tubular epithelial cells.

Main Results:

  • Significantly upregulated TLR2 mRNA and protein in diabetic rat kidneys.
  • Associated with increased MyD88, MCP-1, NF-kappaB activation, and macrophage infiltration.
  • High glucose induced TLR2 mRNA expression in vitro; prominent TLR2 expression observed in human DN renal biopsies.

Conclusions:

  • Enhanced renal TLR2 expression is linked to inflammatory infiltration in diabetic nephropathy.
  • TLR2 may play a significant role in the progression of DN.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.